Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04133415 · ClinicalTrials.gov registry record · NA
Palliative Lattice Stereotactic Body Radiotherapy (SBRT)
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04133415 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 20 participants.
The verdict
NCT04133415, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Standard palliative radiotherapy regimens may provide limited durability of response in large tumors. Thus, there is a clinical need for a new approach. The Lattice SBRT approach will deliver 20 Gy in 5 fractions with partial volume simultaneous integrated boosts to 66.7 Gy. This is hypothesized to improve symptom response, local control, and better prime the tumor microenvironment for immune response compared with standard palliative radiotherapy doses. It is also hypothesized that this will be associated with less toxicity than the traditional homogenous SBRT plan delivered to a large tumor. Blood will be collected before and after Lattice SBRT for evaluation of the peripheral blood immune microenvironment.
Interventions
- PROCEDURE Peripheral blood
- RADIATION Lattice stereotactic body radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-10-31 |
| Est. Completion | 2020-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04133415
The ClinicalTrials.gov registry entry for NCT04133415 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peripheral blood is the first listed.
NCT04133415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04133415 about?
NCT04133415 is a clinical study titled "Palliative Lattice Stereotactic Body Radiotherapy (SBRT)". Standard palliative radiotherapy regimens may provide limited durability of response in large tumors. Thus, there is a clinical need for a new approach. The Lattice SBRT approach will deliver 20 Gy in 5 fractions with partial volume simultaneous integrated boosts to 66.7 Gy. This is hypothesized to ...
What is the current status of trial NCT04133415?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-10-31. Estimated completion is 2020-12-14.
What interventions are being tested in trial NCT04133415?
The interventions under investigation include: Peripheral blood (PROCEDURE), Lattice stereotactic body radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT04133415?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.